Polymer Nanocomposite Encapsulation for Larger, Uniform Batches
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods of polymer encapsulation of nanoparticles like QD or SPION result in agglomeration, limit production to small batches, lack photochemical stability, uniform size, brightness, and specificity to cellular targets, and lack rapid purification protocols.
Innovation Solution
A nanocomposite system where nanoparticles are encapsulated in a polymer with a hydrophobic region and a hydrophilic functional group, using polystyrene-b-polyethylene glycol, allowing for uniform size distribution, high brightness, and specific binding to cellular targets, with protocols for rapid purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current polymer encapsulation methods are used, then nanoparticle encapsulation is achieved, but agglomeration occurs and production is limited to small batches
Solution Approach 1:
The patent uses block copolymers comprising a first block (e.g., polystyrene) and a second block (e.g., polyethylene glycol) with different properties. The first block provides hydrophobic interaction with nanoparticle surfaces while the second block provides hydrophilic stability in aqueous environments, preventing agglomeration and enabling large-scale production of stable nanocomposites.
Solution Approach 2:
Different blocks of the copolymer provide different local functions: the hydrophobic first block interacts with the nanoparticle surface for encapsulation, while the hydrophilic second block interacts with the aqueous environment for stability. This local differentiation of properties prevents agglomeration while maintaining encapsulation efficiency.
2Manufacturing precision
If uniform size distribution is achieved, then nanocomposite consistency is improved, but photochemical stability is compromised
Solution Approach 1:
The patent controls parameters such as block copolymer molecular weight, block ratio, and nanoparticle concentration to achieve optimal encapsulation. By adjusting these parameters, uniform nanocomposite size distribution is obtained while maintaining photochemical stability through proper polymer-nanoparticle interface design and stabilization mechanisms.
3Measurement precision
If specific binding to cellular targets is achieved, then targeting precision is improved, but purification complexity increases
Solution Approach 1:
The patent incorporates fluorescent quantum dots into the nanocomposite structure, providing optical signal changes that enable detection and purification of target-bound nanocomposites. The fluorescent properties allow for straightforward purification protocols based on fluorescence-activated sorting or fluorescence-based detection methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables large batch production of nanocomposites with uniform size and brightness, high binding specificity, and efficient purification, enhancing their applications in biomedicine and biotechnology.
Implementation Method 1
a nanomaterial polymer encapsulation system useful in the production of nanocomposites comprising a hydrophobic nanoparticle encapsulated in a hydrophobic region of a polymer with the external hydrophilic region of the polymer ensuring water-solubility
Implementation Method 2
affording an amine functional group that can be activated to conjugate antibodies, modified antibodies, or antibody fragments, and in a particular embodiments, activated with methyltetrazine glycol-4-N-hydroxysuccinimide esters ('methyltetrazine-PEG4-NHS ester') to allow conjugation of trans-cyclooctyne ('TCO') modified antibody or antibody fragments
Implementation Method 3
one or more of a QD or a SPION
Data Source
AI summary
Generally, a polymer nanomaterial encapsulation system useful in the production of polymer encapsulated nanoparticles comprised of a hydrophobic nanoparticle encapsulated in the hydrophobic region of the polymer with the external hydrophilic region of the polymer ensuring water-solubility and affording a functional group which can be utilized for the production of nanoparticle conjugates. Specifically, particular embodiments include a polymer nanoparticle structure including one or more of: a quantum dot and/or a superparamagnetic iron oxide nanoparticle and/or an upconverting nanoparticle, encapsulated in polystyrene-b-polyethylene glycol amine for the production of antibody conjugates useful in the capture of cellular targets.


